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ANTIKANDIDA, ANTIOKSIDAN, KETOKSIKAN DAN PEMENCILAN 
SEBATIAN DARIPADA BIJI Cassia fistula 
 
ABSTRAK 
Dalam kajian ini, ekstrak metanol biji Cassia fistula telah dicerakinkan untuk 
aktiviti antimikrob dan antioksidan, dipencilkan, ditulenkan untuk sebatian bioaktif serta 
ditaksir kesan toksiknya. Ekstrak biji telah diuji untuk aktiviti antimikrob terhadap 
bacteria Gram-positif dan negatif serta jenis kulat yang mempunyai kepentingan 
perubatan. Aktiviti antimikrob telah ditentukan melalui kaedah peresapan disk dan 
pencairan kaldu. Ekstrak didapati berkesan terhadap mikroorganisma ujian dan nilai 
kepekatan perencatan minimum (MIC) didapti berada dalam julat 1.563-50.00 mg/mL. 
Ekstrak biji menunjukkan aktiviti yang amat baik terhadap kulat patogen C. albicans 
dengan nilai MIC 6.25 mg/mL, dan keputusan ini disahkan melalui kajian asai bunuh 
mengikut masa. Kesan ekstrak biji C. fistula terhadap C. albicans telah diuji melalui 
perubahan dalam profil pertumbuhannya, dan ini mengesahkan aktiviti antikandida 
terhadap C. albicans. Metamorfosis morfologi C. albicans kawalan serta yang dirawat 
dengan ekstrak yang dicerap melalui SEM dan TEM menunjukkan perubahan yang 
ketara terhadap dinding luar sel dan kandungan sitoplasma C. albicans serta kemusnahan 
sel yis tersebut yang didedahkan pada ekstrak biji dengan kepekatan 6.25 mg/mL selama 
36 jam. Analisis penyaringan fitokimia ekstrak biji C. fistula menunjukkan kehadiran 
lima metabolit sekunder utama termasuk antrakuinon, terpenoid, flavonoid, saponin, tanin 
serta ketidakhadiran alkaloid dan gula penurunan. Maka, penulenan dan identifikasi lanjutan 
sebatian bioaktif telah dilakukan dengan menggunakan pelbagai teknik kromatografi. Dua jalur 
utama telah dipisahkan dengan nilai Rf 0.39 dan 0.69 melalui kaedah kromatografi. Seterusnya, 
xix 
 
pecahan aktif yang telah dipencilkan tadi dianalisis dengan mengunakan kaedah HPLC dan 
LC/MS, dan keputusan menghasilkan puncak jelas yang menunjukkan kehadiran sebatian bioaktif 
utama dengan aktiviti antikandida. Analisis MS terhadap komponen ini telah seterusnya disahkan 
sebagai roseanon. Aktiviti antioksidan ekstrak biji C. fistula telah diuji dengan menggunakan 
kaedah DPPH dan keputusan menunjukkan aktiviti penjerapan dengan nilai 25.2% dan nilai IC50 
11.07 mg/mL. Kandungan jumlah fenol dan flavonoid didapati sangat tinggi di dalam ekstrak biji 
iaitu sebanyak 474.25 mg bersamaan dengan asid galik per gram berat sampel kering dan 70.86 
mg bersamaan katekin per gram berat sampel kering, masing-masing. Ekstrak biji seterusnya diuji 
untuk asai perencatan xantin oksidase dan ekstrak didapati mempamerkan aktiviti perencatan 
dengan nilai sebanyak 64.56% dan nilai IC50 49.5 µg/mL. Kajian awal ketoksikan ekstrak biji C. 
fistula telah dilakukan dengan menggunakan esei kematian anak udang brin dan kaedah 
ketoksikan oral akut. Keputusan menunjukkan ekstrak biji C. fistula tidak toksik terhadap 
Artemia salina dengan nilai LC50 2.11 mg/mL. Keputusan ini telah disahkan melalui 
kajian ketoksikan oral akut dan pemberian ekstrak pada dos yang tinggi iaitu sebanyak 
5,000 mg/kg berat badan melalui oral yang tidak menunjukkan sebarang kematian atau 
bukti kesan sampingan. Ini membuktikan bahawa ekstrak biji C. fistula yang diuji adalah 
tidak toksik. Analisis histopatologi organ penting buah pinggang, hati, paru-paru, limpa 
dan jantung telah mengesahkan keputusan tersebut. Sebagai kesimpulan keputusan 
kedua-dua ujian toksisiti ini menunjukkan ekstrak C. fistula tidak toksik dan adalah 
selamat untuk digunakan bagi tujuan komersil khasnya dalam memajukan agen 
antikandida. 
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ANTICANDIDAL, ANTIOXIDANT, TOXICITY STUDIES AND ISOLATION OF 
COMPOUNDS FROM Cassia fistula SEEDS  
 
ABSTRACT 
In the present study, methanol seeds extract of Cassia fistula was assayed for 
antimicrobial and antioxidant activities, isolated and purified for bioactive compounds as 
well as evaluated for the toxicity effect. The seeds extract was tested for potential 
antimicrobial activity against medically important Gram-positive and Gram-negative 
bacteria and fungal strains. The antimicrobial activity was determined by the disc 
diffusion and the broth dilution methods. The extract was effective on tested 
microorganism and the minimum inhibitory concentration (MIC) values were found in 
the range of 1.563-50.00 mg/mL. The seeds extract showed a favourable activity against 
pathogenic fungi C. albicans with MIC value 6.25 mg/mL, and this was confirmed by 
time kill assay study. The effect of C. fistula seeds extract on C. albican was examined 
by the alteration in normal growth profile curve and this further confirms the anticandidal 
activity on C. albicans. The SEM and TEM observations were carried out to distinguish 
the metamorphosis in the morphology of control and seeds extract treated C. albicans.  
The results revealed adverse effects on the outer cell wall and cytoplasmic content of the 
C. albicans and complete collapsed of the yeast cell exposed to seeds extract at 
concentration 6.25 mg/mL for 36 hrs. The phytochemical screening analysis of C. fistula 
seeds extract revealed the presence of five major secondary metabolites including 
anthraquinone, terpenoids, flavonoids, saponins, tannins and the absence of alkaloids and 
reducing sugars. Hence, further purification and identification of bioactive compounds 
were done by various chromatography techniques. Two separated bands were separated 
xxi 
 
from the developed chromatogram with Rf value 0.39 and 0.69. The isolated active 
fractions were tested via HPLC and LC/MS, and the results revealed distinct peaks which 
indicated the presence of major bioactive compound with anticandidal activity. The MS 
analysis on this component was subsequently confirmed as roseanone. The antioxidant 
activity of C. fistula seeds extract was evaluated by DPPH assay and the result revealed 
the scavenging activity with value 25.2% and IC50 value 11.07 mg/mL. Total phenolic 
and flavonoid contents were found to be highest in seeds extract with 474.25 mg of gallic 
acid per gram dry sample and 70.86 mg of catechin equivalent per gram of sample 
respectively. The seeds extract was further evaluated for the xanthine oxidase inhibitory 
assay and the seeds extract exhibited inhibitory activity with value 64.56% and IC50 value 
of 49.5 µg/mL. Preliminary toxicity properties of C. fistula seeds extract was investigated 
by brine shrimp lethality assay and acute oral toxicity study. The result indicated the C. 
fistula seeds extract was not toxic against Artemia salina with LC50 value 2.11 mg/mL. 
Further confirmation of this finding obtained from acute oral toxicity study and oral 
administration of seeds extract at the highest dose of 5,000 mg/kg, resulted in no 
mortalities or evidences of adverse effects, implying that C. fistula seeds extract was 
nontoxic. Histopathology analysis of the vital organs of kidney, liver, lung, spleen and 
heart confirmed the evidence. In conclusion, the results of both toxicity tests confirmed 
that C. fistula seeds extract was nontoxic and hence safe for commercial utilization 
especially for the development of anticandidal agent. 
1 
 
CHAPTER 1.0: INTRODUCTION 
 
In pre-globalization era, infectious diseases caused by microorganisms are still a 
major threat to public health due to drastic alarming increase in rate of antibiotics 
resistance. Many people around the world are suffering from infectious diseases such as 
AIDS, malaria and tuberculosis.  The impact is particularly large in developing countries, 
mainly due to the relative unavailability of medicines and the emergence of widespread 
drug resistance. The antibiotic resistance is a dangerous trait which enables microbes to 
survive and continue to grow instead of being inhibit or destroy, and this raise the risk of 
medical miracles at all times. Moreover, the ability of microorganisms to inactivate 
current drugs makes the situation even more complicated.  
During the past several years, infectious diseases caused by pathogenic 
microorganisms associated with adherence of biofilms has determined as the major 
trigger of human morbidity and mortality in non-industrialized countries (Ramage et al., 
2001). In addition, huge modifications in genetic variant of target pathogens are 
subsequently developing resistance to commercially available antibiotics (Hawkey, 
1998). Therefore, increasing in resistance to antibiotics greatly demonstrates the potential 
for the rapid spread of resistant microbial strains and which could stimulate permissive 
life-threatening infections. One example of biofilm associated microorganism is the 
Candida albicans. It is a well known opportunistic fungal pathogen capable of triggering 
infections by its biofilm mode of growth particularly in immunocompromised patients 
(Jain et al., 2007) such as cancer, AIDS or HIV. C. albicans is able to colonize on 
mucosal surface and epithelium by its biofilms and have important clinical repercussions 
due to their increased resistance to antifungal agents which result in treatment failure.  
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Therefore, research on new drugs development must continue and all possible strategies 
should be explored to combat antibiotic-resistant fungal pathogens which are mutant to 
commercially available antifungal agents (Clark and Walker, 1999).  
Hence, natural products are one of the best alternatives to be explored to combat 
antibiotic resistant Candidal pathogens. In general, natural products have played a pivotal 
role in antibiotic drug discovery with most antimicrobial drugs being derived from a 
natural product or natural product lead. However, the rapid onset of resistance to most 
antimicrobial drugs diminishes their effectiveness considerably and necessitates a 
constant supply of new antibiotics as alternative treatment for infectious diseases. The 
biologically active compounds isolated from plants that contribute to medicinal field are 
largely known as plant-derived drugs. Furthermore, the activities of compounds found in 
natural products are thousand times much different compared to the available synthetic 
products. This may due to the variability in chemical structures of secondary metabolites 
produced by natural products with increasing potential in new mechanisms to defense the 
pathogenic microorganisms (Cowan, 1999). Traditionally, the terrestrial plants were the 
major source which possesses abundant pharmaceutical agents and their potential uses 
have been documented until today. Recently, many new metabolites have been identified 
from plant-based natural products and many of which possess highly interesting 
pharmaceutical properties. Apart from that, natural products are often very different in 
their chemical structures compared to those found from synthetic compounds. Moreover, 
most of the synthetic compounds are derivatives of these natural compounds. Therefore, 
natural products based pharmaceuticals in many cases provide completely new 
pharmacological mode of actions. Thus, this has attracted the interest of numerous natural 
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product researchers to further extend their finding towards natural products (Cowan, 
1999).          
In the past few decades, diseases caused by free radicals have been increased 
astronomically due to less consumption of high antioxidant food supplements. Natural 
products also can play an important role to overcome diseases caused by free radicals. 
Moreover, the food product from natural resources contains high antioxidant properties 
such as green tea, vegetables and fruits. Since antioxidant compounds possess the power 
to reduce the reaction of ROS in tissue damage, therefore such situation diverts 
researches towards finding new products with antioxidative properties from natural 
resources such as medicinal plants, which are very active domains in today’s research 
world. Although humans and other organisms possess antioxidant defense enzymes to 
protect against oxidative damage but they are totally insufficient in preventing the overall 
damage (Mau et al., 2002). Antioxidant supplements or foods containing antioxidants 
may help the human body to reduce the oxidative damage (Yanga et al., 2002) since 
these sources are rich with various types of bioactive compounds able to donate electrons 
to terminate the chain reactions. Hence, in this study the antioxidant activity of C. fistula 
seeds extract was explored.      
The exploration of local medicinal plants in this study also brings economic 
values to the countries. Today herbal markets in the world mainly United States, 
Germany, France, India and Japan have become huge potential markets with a great room 
for scientific research and technology. According to statistics being reported, Europe has 
a huge herbal market with about $ 70 billion a year and is growing at the rate of 6% 
annually. Germany and France, both the largest European market, use herbs as 
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pharmaceutical prescriptions and their sales channels were around $ 7.1 billion in 2003 
and may be over $ 25 billion. Apart from that, the UK which ranged as the fourth largest 
European market showed a slight rise from $ 0.5 billion in 2003 to $ 0.7 billion in 2007. 
Herbs and botanical sales of US were $ 4.4 billion in 2005, with an estimated growth rate 
of nearly 4% and the sales grew up to $ 4.6 billion in 2006 and currently estimates to 
about $ 4.8 billion (Verma and Singh, 2008). In India the market for ayurvedic medicines 
is estimated to be expanding at 20% annually and the sales of medicinal plants have 
grown by nearly 25% over the past 10 years. According to the statistic analysis reported 
by the Export Import (EXIM) Bank, the growth rate of international market for medicinal 
plants related market were 7% for per annum in India in 2004. In addition, the shares in 
the world herbal market for both China and India were $ 6 and $ 1 billion respectively 
and it is rapidly growing yearly form 2003 to 2006 (Verma and Singh, 2008). World 
Health Organization (WHO) believes that the international market for herbal products 
estimated to be $ 62 billion is poised to grow up to $ 5 trillion by the year 2050 (Rath, 
2005). All the statistical data above are evidence for the bright future of natural product-
based antimicrobial development program. If C. fistula seeds extract was chosen by any 
pharmaceutical companies will bring economics benefits to the local famers.    
Hence, the current research was undertaken to explore the potential 
pharmaceutical activities of C. fistula seeds extract as an anticandidal and antioxidant 
agents.   
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1.1 Objectives 
The current study was undertaken with the following objectives:   
 To investigate the rationale of the usage of C. fistula as a curative in 
traditional medicine by studying the antimicrobial and antioxidant activities.  
 To study in vitro and in vivo toxicity of C. fistula seeds extract.  
 To isolate and identify the active fractions or bioactive compound(s) with 
anticandidal activity from C. fistula seeds extract by using column 
chromatography, preparative TLC, bioautography,  HPLC and LCMS 
techniques. 
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CHAPTER 2.0: LITERATURE REVIEW 
 
2.1 Antimicrobial agents   
 
Infectious diseases are still the second leading cause of death worldwide and the 
number of emerging or re-emerging bacterial, fungal and viral pathogens are continue to 
increase. This signifies the need of substances to control the microorganisms in 
prevention and curing the diseases caused by their actions. An antimicrobial agent is one 
of the substances that kills or inhibits the growth and prevents damage due to the action 
of infectious microorganisms. Microbiologists have distinguished two groups of 
antimicrobial agents used to treat infectious diseases (Chattopadhyay et al., 2010). Firstly 
the antibiotics, which are natural substances produced by certain group of 
microorganisms with potential to inhibit and kill growth of other microorganisms and 
secondly, chemotherapeutics agents which are chemically synthesized. In medical and 
pharmaceutical worlds, all antimicrobial agents used in the treatment of diseases are 
referred as antibiotics which interpret the word literally. Therefore, today the term 
antibiotic is largely used to refer to any drug that attempts to prevent or cure infectious 
diseases. Meanwhile, substances that kill or inhibit growth of fungi are known as 
antifungal agents (McDonnell, 2007).   
The discovery of a powerful bactericidal substance, the penicillin by Alexander 
Fleming which possesses a broad antimicrobial activity begins the golden period of pre-
antibiotics era and until now the drug discovery has been largely dominated by the 
whole-cell screening assay. The capability of the substances to inhibit the growth of the 
multiplying bacteria is preferred best as antimicrobial agents, although their reaction 
mechanism behind the action is not always understandable. However, this approach was 
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successful in the early days of large synthetic chemical libraries with novel chemistries or 
naturally occurring antimicrobials including peptides (Bax et al., 1998; Overbye and 
Barrett, 2005). In the past two decades, there has been unprecedented activity in the 
discovery and development of new antimicrobial agents and such situation resulted in 
unrelated research and discovery efforts in many different chemical areas. In addition, the 
technical advances in penicillin chemistry have helped in subsequent rapid development 
of cephalosporins and other beta-lactams leading to development of structure activity 
relationship (SAR) which directs the chemical modification of antibiotics to improve 
bacterial activity. This approach also triggers the discovery of new antifungal agents 
active against all pathogenic fungus that had acquired resistance to commercially 
available agents (Gootz, 1990).  
2.1.1 Resistant microorganisms towards available antimicrobial agents 
Antimicrobial agent medications are used to kill pathogenic microorganisms, 
which can cause severe infections and diseases. The agents have made major contribution 
to human health and many diseases leading to death can now be treated effectively with 
antibiotics. However, some microorganisms have become resistant to commonly used 
antimicrobial agents. The antibiotic resistant strains are not controlled or killed by 
antibiotics and thereby are able to survive and multiply even in the presence of an 
antibiotic. Most of infection-caused strains become resistant to one or two antibiotics and 
in certain cases some become resistant to more antibiotics which are known as multi-
resistant organisms (MROs). The molecular mechanisms by which bacteria become 
resistant to antimicrobial agents are diverse and complex. Overall, the mechanisms of 
resistant can be categorized according to their principle mechanisms of action known as 
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genetic and biological alterations (Brazas et al., 2007). The genetic mechanisms mostly 
involve in acquisition of new genetic material by antimicrobial susceptible 
microorganism from resistant strains which occurs through conjugation, transformation 
or transduction with transposons, often facilitate the incorporation of the multiple 
resistance genes into the host genome or plasmids (Foley
 
and Lynne, 2008). The 
biological mechanism or also known as natural selection generally involves mutation. 
When bacterial strains grow rapidly and mutate frequently at a rate of 1 in every 100,000 
to in every million, such situation triggers biochemical alteration and this often leads to 
DNA base pair mutation which finally enhances changes in protein shape, function or 
both. The potential of mutation increases the chances for development of antibiotics 
resistant strains (Hutter et al., 2004).  
2.1.2 Types of antimicrobial agents and the resistant mechanisms 
Antimicrobial chemotherapy has played an important role to overcome severe 
infectious diseases caused by microbial pathogens. Antifungal and antibacterial agents 
can be classified based on the chemical structures and its corresponding therapeutic 
potential mechanisms. In addition, there are three new azole drugs that have been 
developed, and used in both systemic and superficial fungal infections. The voriconazole, 
ravuconazole and posaconazole are triazoles, with broad-spectrum activity. Voriconazole 
has a high bioavailability, and has been used with success in immunocompromised 
patients with invasive fungal infections. Ravuconazole has shown efficacy in candidiasis 
in immunocompromised patients, and onychomycosis in healthy patients. Meanwhile, the 
preliminary in vivo studies with posaconazole indicated potential use in a variety of 
invasive fungal infections including oropharyngeal candidiasis. Echinocandins and 
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pneumocandins are a new class of antifungals, which act as fungal cell wall beta-(1, 3)-
D-glucan synthase enzyme complex inhibitors (Gupte et al., 2002). Other antibacterial 
agents are β-lactams (penicillins and cephalosporins), macrolides (erythromycin and 
azithromycin), tetracyclines (tetracycline), aminoglycoside (streptomycin) and 
chloramphenicols (Gootz, 1990). 
Infection caused by microbial strain which is resistant to available anti-infectious 
agents, is particularly a serious problem in patients at risk for infections. Most resistances 
currently seen are the result of plasmid transfer rather than mutational events. However, 
extensive use of antimicrobial agents in hospitals has caused the selection of organisms 
resistant to many agents by virtue of chromosomally mediated mechanisms (Harold, 
1984). Many researchers have documented the outline of resistance mechanisms by 
which bacteria or fungi evade the antimicrobial agents. In general, these mechanisms can 
be divided into six major categories (Figure 2.1): 1. Modification of a target enzyme 
where all antimicrobial agents have specific functions towards their target 
microorganisms to which they interact. In many cases, if the microorganism can modify a 
target enzyme, then that enzyme may become insensitive to the former inhibitor but still 
functions and the organisms will not be inhibited (Harold, 1984). 2. Reduction in 
physiologic importance of target. The mechanism of resistance is due to reduction in the 
physiological importance of target. In certain streptococci and some gram-negative 
species, the role of peptidoglycan in maintaining bacterial cell viability is significantly 
reduced (Shockman et al., 1981). 3. Duplication of target enzyme. Some bacterial strain 
tends to duplicate targets and this is seen with trimethoprim in which an altered 
dihydrofolate reductase decreases the affinity for trimethoprim to be synthesized. 
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Figure 2.1: Major biochemical mechanisms of antibiotics resistance 
   
Source: http://chem3513-2007.pbworks.com/w/page/15648409/Antibiotic-Resistance 
 
Altered penicillin-binding proteins have also been found in beta-lactam-resistant 
Streptococcus pneumoniae, Neustria gonorrhoeae, and Staphylococcus aureus 
(Karchmer et al., 1983). 4. Prevention of access to the target. Such situation triggers to 
prevent the access of the antimicrobial agent to its receptor and this leads to alteration of 
porin channels, as occurs with beta-lactam antibiotics and aminoglycosides, or loss of a 
transport system which is an extremely effective form of bacteria resistant to fosfomycin 
and fosmidomycin.  Resistance  to  tetracycline  is  primarily  the  result  of exclusion  of  
the drug by  insertion  of proteins  in the  bacterial membrane (Chopra and Howe, 1978). 
5. Depression of metabolic activity that normally converts an inert agent into an active 
agent. Some bacteria may depress their usual metabolic pathways to avoid activating an 
agent, as occurs with metronidazole which must be converted to an active form in the 
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bacteria (Georgopapadaku and Liu, 1980). 6. Synthesis of enzymes that inactivate 
antimicrobial agents or modify the agent to alter entry or binding receptor. Finally, 
bacteria can synthesize enzymes that inactivate the agent by destroying the substance, 
such as the beta-lactamases (DelBene et al., 1979) or can modify the antibacterial agents. 
This  modified  drug either  enters  the  bacterial  cell  poorly  or, when  it enters  the  cell,  
fails  to  bind  adequately  to  its  target  (Bryan, 1982).   
2.1.3 Synergetic and antagonistic actions of antimicrobial agents  
Synergism refers to the combined action of two drugs to produce a marked 
increase in the bactericidal rate within first 24 hours of exposure as compared with the 
rate of either drug alone. Such phenomenon expects greater number of bacteria being 
killed compared to simple summation of single drug effect. Antagonism refers to a 
marked decrease in the early bactericidal rate as compared with that of the more active 
single drug even though the combination after prolonged incubation may kill more 
organisms than either drug alone. These definitions have been chosen because they seem 
to correlate well with results in the treatment of experimental infections in mice and with 
certain clinical evidence (Gunnison et al., 1955). 
2.2 Plants as potential natural source  
Mankind has been using plants as therapeutic agents for thousands of years and 
continues to rely on them for primary health care. Plants do not only provide food and 
shelter but serve humanity to cure different ailments and serve as an excellent source for 
bioactive compounds which contain potent antimicrobial activities (Khan et al., 2010). 
Plants that act as herbal medicines are also defined as traditional or natural medicines, 
which exist in one way or another in different cultures or civilizations such as Indian, 
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Egyptians, Western, Chinese, Japan and Greco-Arab or Unani. Medicinal plants have 
always been the source of medicine since they possess pharmacological activities and 
potential therapeutic uses. Rural areas of many developing countries claim that medicinal 
plant products are cheaper, effective and impart least effects as compared synthetic 
products not affordable to those with low-income (Ahsan et al., 2009). Medicinal plants 
research have been supported world widely, the primary goal behind such situation is the 
recognition of active principle medicinal plants and the pharmacological investigation of 
the extracts which enhance their safety, effectiveness and constant activities. It is 
estimated that at the beginning of 21st century, 11% of 252 drugs considered as basic 
essentials by World Health Organization (WHO) are exclusively of flowering plant origin 
(Rates, 2001). 
Interest in medicinal plants as re-emerging diseases has been fuelled by the rising 
costs of prescription drugs in maintaining personal health and the bioprospecting of new 
plant-derived drugs. Furthermore, indiscriminate use of antimicrobial drugs, have 
developed microorganisms resistance to many antibiotics. This creates several clinical 
problems in the treatment of infectious diseases and stimulates interests in isolation of 
plant derived-drugs in a number of countries. Substances with diverse pharmacological 
properties that can either inhibit the growth of pathogens or kill them with least toxic to 
host cells are considered as candidates for developing new antimicrobial agents (Ahmad 
and Beg, 2001). Based on current research and financial investments, medicinal plants 
seem continue to play an important role as treatment in various ailments (Hoareau and 
DaSilva, 1999). Since ancient time, plants have served as natural source in treatment of 
various kinds of diseases; therefore, scientists have been widely using these renewable 
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resources to produce a new generation of therapeutic solutions with the help of 
biotechnology.    
The search for new anti-infective agents has been taken over by many research 
groups in the field of ethnopharmacology. Ethnopharmacology provides as an 
opportunity for both multidisciplinary and interdisciplinary scientific collaboration 
between the investigations of botany, pharmacology and toxicology, chemistry, 
anthropology and sociology. Now research on natural molecules and products primarily 
focuses on medicinal plants since they can be sourced more easily and be selected on the 
basis of their ethnomedicinal use (Verpoorte et al., 2005). The discovery of plant-derived 
drugs allows rational planning of new drugs with new biological activity not related to 
the known compounds (Rates, 2001; Arya et al., 2002). It is expected that plant 
compounds with diverse chemical structure have great pharmacological effects against 
drug-resistant microbial pathogens compared to currently used antibiotics (Duarte et al., 
2005).                      
2.2.1 Plant as antimicrobial source 
Plants have been used as therapeutic agents for thousands of years and continue to 
rely on them for primary health care needs. “An apple a day keeps the doctor way” 
according to the traditional American rhyme, and since ancient time plant source has 
been widely known to have high potential as healing powers (Cowan, 1999). Further 
acquaintance with different ethnic groups has gain knowledge of ethnopharmacology use 
of certain compounds from various plant parts including stem, root, leaf, flowers and 
fruits, based upon the understanding of animal/insect- plant interrelation (Doughari et al., 
2011).  
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According to Hippocrates, the Father of modern medicine who claimed the gold 
coin “Food as medicine and medicine as food” mentioned about 300 to 400 medicinal 
plants with pharmaceutical properties in late fifty century B.C (Schultes, 1978). Apart 
from that, it is estimated that there are 250,000 to 500,000 species of plants on Earth 
(Borris, 1996) and relatively small percentage of these are used as foods by both humans 
and animal species. In the West, the Renaissance years saw a revival of ancient medicine, 
which was built largely on plant medicinal. Native American use of plant medicinal has 
been reviewed extensively in a series of articles by Moerman (1996). He reported that 
while 1,625 species of plants have been used by various Native American groups as food 
2,564 have found use as drugs. Furthermore, Asian cultures were also busy compiling 
their own pharmacopoeia using medicinal plants. Today many people are interested in 
having more autonomy over their medical care. In addition, multitude plant compounds 
are readily available over the counter from herbal suppliers and also natural-food stores 
for self-medication to cure almost half of infectious diseases around the world. The use of 
plant extracts, as alternative forms of medical treatments and is enjoying its great 
popularity since late 1990s (Klink, 1997). Thus, medicinal plants make many researchers 
to be alert towards their traditional uses through the verification of pharmacological 
effects which can be natural composite source activity as new anti-infectious agents.   
2.2.2 Plant-derived antimicrobial agents 
Plant-derived antimicrobial agents were discovered from different sources of 
plant parts and plant origins for many years, and the plant metabolites generally were 
considered as a source of antinutritional factor. There are a number of medicinal plants 
with their pharmacological and biological properties such as the essential oils of 
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cinnamon (Cinnamomum cassia), were found to possess in vitro antimicrobial properties 
and shown to inhibit the growth of Bacillus cereus (Kalemba and Kunicka, 2003; Valero 
and Salmeron, 2003). Alcoholic extracts of cinnamon were found most effective against 
Helicobacter pylori, in reducing its growth (Tabak et al., 1996). The ethanol or water 
extract of cinnamon bark inhibited the activity of bacterial endotoxin. The bark of 
Cinnamomum zeylanicum was found effective against fluconazole resistant Candida 
species, which is an emerging problem. Whereby, Curcuma longa (Turmeric) are 
considered to have natural medicinal properties, including antibacterial, anti-
inflammatory, antineoplastic, and analgesic activities because they contains a number of 
moniterpenoids, sesquiterpenoids, and curcuminoids (Tang and Eisenbrand, 1992; Fang 
et al., 2003). It is also reported to have insecticidal activity (Chander et al., 1991a, b). In 
addition, wound healing and detoxifying properties of curcumin have also received 
considerable attention (Joe et al., 2004). Curcumin, an active antioxidant from C. longa 
did not produce any effect on aflatoxin production by Aspergillus parasiticus (Soni et al., 
1992). Meanwhile, the Piper nigrum (Black pepper) is used to treat asthma, chronic 
indigestion, colon toxins, obesity, sinus congestion, fever, intermittent fever, cold 
extremities, colic, gastric ailments and diarrhea. It has been shown to have antimicrobial 
activity (Perez and Anesini, 1994; Dorman and Deans, 2000). The both aqueous and 
ethanol extracts of black pepper screened for antibacterial activity against a penicillin G 
resistant strain of Staphylococcus aureus, showed antibacterial activity (Perez and 
Anesini, 1994). The Thymus vulgaris (Thyme) components are becoming increasingly 
popular as a naturally occurring antimicrobial and also as an antioxidant agent (Dursun et 
al., 2003). Thyme showed broad antibacterial activity by inhibiting the growth of both 
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gram-positive and gram-negative bacteria. However, gram positive bacteria Clostridium 
botulinum and C. perfringens appeared to be more sensitive than the gram-negative 
organisms (Nevas et al., 2004). The alcohol and ethanol extracts of thyme, thyme 
essential oil, thymol and carvacrol were found to have strong inhibition activity against 
Bacillus subtilis, Shigella sonnei, E. coli (Fan and Chen, 2001). Aqueous extracts of 
thyme significantlt inhibited the growth of H. pylori, reducing its growth (Tabak et al., 
1996). Thymol showed antagonistic effect against S. sonnei in anaerobic conditions in 
vitro (Juven et al., 1994). 
2.3 Quantitative evaluation of antimicrobial activity  
Antimicrobial agents are categories based on their mechanisms of action, 
chemical structure or spectrum of activity. Microorganisms that are inhibited by 
antimicrobial agents are target-specific and dependent upon the drug’s mode of action. 
Antimicrobial activity of natural extract and pure compounds can be observed based on 
the growth response of particular microorganisms placed in contact with that active 
compound. There are a number of methods available for detecting activity however, since 
these methods are not equally sensitive or not based upon the same principle, results will 
be profoundly influenced by the method (Cos et al., 2006). In general, the antifungal and 
antibacterial test methods are classified into three main groups as follows. 
2.3.1 Agar-diffusion method   
In the agar-diffusion technique, a reservoir containing the test compound at a 
known concentration is brought into contact with an inoculated medium and the diameter 
of the clear zone around the reservoir is measured at the end of the incubation period. The 
inoculated system is kept at a lower temperature for several hours before incubation to 
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favours compound diffusion over microbial growth, thereby enhancing the inhibition 
zone. Many types of reservoir can be used, such as filter paper discs, stainless steel 
cylinders placed on the surface and holes punched in the medium. The hole-punch 
method is the only suitable diffusion technique for aqueous extracts, because interference 
by particulate matter is much less than with other types of reservoirs. Meanwhile, small 
sample requirements and the possibility to test up to six extracts per plate against a single 
microorganism are specific advantages (Hadacek and Greger, 2000). In general, the 
relative antimicrobial potency of different samples may not always be compared. This is 
due to the differences in physical properties, such as solubility, volatility and diffusion 
characteristic in agar (Cos et al., 2006).  
2.3.2 Dilution method 
In the dilution method, test compounds are mixed with a suitable medium that has 
previously been inoculated with the test organism. This method can be carried out in 
liquid as well as in solid media. The growth of test microorganism can be measured in 
number of ways such as agar dilution method and liquid or broth dilution method based 
on the Minimal Inhibitory Concentration (MIC), defined as the lowest concentration of 
antimicrobial agent which inhibits any visible microbial growth by plating-out samples 
after incubation. The turbidity and redox-indicators are most frequently used in liquid or 
broth dilution methods. Turbidity can be estimated visually or obtained more accurately 
by measuring the optical density at 405nm. However, test samples that are not fully 
soluble may interfere with turbidity readings, emphasizing the need for a negative or 
sterility control (Cos et al., 2006).  
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2.3.3 Bioautographic method 
Bioautography is a useful technique to determine bioactive compound with 
antimicrobial activity from plant extract. TLC bioautographic methods combine 
chromatographic separation and in situ activity determination facilitating the localization 
and target-directed isolation of active constituents in a mixture (Sasidharan et al., 2011). 
Traditionally, bioautographic technique uses the growth inhibition of microorganisms to 
detect antimicrobial components of extracts chromatographed on a TLC layer. This 
methodology has been considered as the most efficacious assay for the detection of anti 
microbial compounds (Shahverdi et al., 2007). Bioautographic localizes the antimicrobial 
activity on a chromatogram using three approaches: 1) Direct bioautography, where the 
microorganism grows directly on the thin layer chromatographic plate, 2) Contact 
bioautography, where the antimicrobial compounds are transferred from the TLC plate to 
an inoculated agar plate through direct contact, and 3) Agar-overlay bioautography, 
where a seeded agar medium is applied directly onto the TLC plate (Hamburger and 
Cordell, 1987; Rahalison et al., 1991). The inhibition zones produced on TLC plates by 
one of the above bioautographic techniques will be used to visualize the position of the 
bioactive compound with antimicrobial activity in the TLC fingerprint with reference to 
Rf values (Homans and Fuchs, 1970). Despite high sensitivity, its applicability is limited 
to microorganisms that easily grow on TLC plates. Since biouatography allows localizing 
antimicrobial activities of an extract on the chromatogram, thus it supports a quick search 
for new active antimicrobial compounds through bioassay guided isolation (Cos et al., 
2006). The agar overlay method is advantageous in that, it uses very little amount of 
sample compared to the normal disc diffusion method (Sasidharan et al., 2011).  
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2.4 Antioxidants 
Oxidation is essential to many living organisms for the production of energy to 
fuel biological processes. However, free radicals and other reactive oxygen species 
(ROS) are continuously produced in vivo by the body itself as byproducts of metabolic 
processes resulting in dangerous culprit of cell death and tissue damages. The excessive 
free radicals production and lipid peroxidation are actively involved in the pathogenesis 
of a wide number of diseases including atherosclerosis (Parthasarathy et al., 1998), 
cardiac and cerebral ischemia, neurodegenerative disorders, carcinogenesis and the aging 
process (Hu et al., 2000). Oxygen free radicals can initiate lipid peroxidation which 
stimulates glycation of protein, inactivation of enzymes and alteration in the structure and 
function of collagen basements and other membranes, and also crucial in the long-term 
complication of diabetes (Saha et al., 2004; Polterait, 1997).  
Antioxidants are vital substances which possess the ability to protect the body 
from damage caused by free radical induced oxidative stress (Ozsoy et al., 2008a, b). 
Antioxidants may also be defined as radical scavengers which protect human body 
against free radicals that slow down or stop free radical oxidation. Antioxidants minimize 
radical-caused damages by reducing the energy of free radicals. The reduced energy 
prevents free radicals from forming, or interrupting the oxidation chain reaction itself. 
Furthermore to control the number of free radicals, the body produces enzymatic 
scavengers called endogenous antioxidants such as superoxide dismutase (SOD). Even 
with maximum production of endogenous antioxidants, the body’s defenses sometimes 
can be overwhelmed; therefore in such a case, exogenous antioxidants particularly 
vitamins, minerals and herbs may be used to aid the body (Greenly, 2004). 
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Plant-derived substances such as vitamins, flavonoids, catechins and anthocyanins 
are secondary metabolites widely distributed with antioxidant and antiradical properties, 
and becoming increasing suggested dietary factors (Ferguson, 2001). Medicinal plants 
and herbs are potent biochemical with phytomedicine properties and have obtained a 
wondrous assortment of industrial chemicals. This has attracted worldwide trend towards 
the use of natural phytochemicals present in plant sources such as beans, berry crops, tea, 
oilseeds and vegetables. Several herbs and spices have been reported for antioxidant 
activity including sage, chili pepper, white pepper ginger, nutmeg, turmeric and several 
Chinese medicinal plants extracts (Ara and Nur, 2009).  
2.5 Toxicological tests 
Paracelsus, the Father of toxicology said, “All substances are poison and nothing 
is without poison, only the dose of that substances makes it poison”. Ancient Tamil 
literatures cite “The over dose of a substance makes the poison”. Toxicology derived 
from the Greek words of ‘toxicos’ and ‘logos’, means science that studies the adverse 
effects of chemicals and biological substances for example heavy metals like cadmium, 
chromium, copper and mercury. Toxicology study is to evaluate the plant extract effects 
on human, animal or microbes. Apart from that, toxicology study is an inter-disciplinary 
science that integrates the principles and methods of many fields such as chemistry, 
biology, pharmacology, molecular biology, physiology and medicine (Sasidharan et al., 
2008b).  
Toxicology study plays a crucial role in identification and isolation of new 
compounds from natural resources. In addition, the validation and selection of primary 
toxicological screening methods are essential to guarantee a sound selection of extracts or 
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molecules with relevant pharmacological action and worthy of following-up. In practical, 
it is an important method to declare the safety of a developed drug at lower dosages to 
compare the safety of higher dosages. Primary toxicological screening methods are 
generally designed for rapid screening of large numbers of extracts with biologically 
active compounds. These methods should be simple, precise and easy to implement and 
produce results quickly and preferably at low costs. The primary toxicity assay included 
the Brine shrimp lethality test and Oral acute toxicity test.  
2.5.1 Brine shrimp lethality test 
The Brine shrimp Artemia salina L. (Artemiidae), is an invertebrate component of 
the fauna of saline aquatic and marine ecosystems. It plays an important role in the 
energy flow of the food chain (Sanchez-Fortun et al., 1995). Artemia salina is used in 
laboratory bioassay in order to determine toxicity through the estimation of medium 
lethal concentration (LC50 values) (Lewan et al., 1992), which have been reported for a 
series of toxins and plant, extracts (Meyer et al., 1982). This assay is considered a useful 
tool for preliminary assessment of toxicity since brine shrimp is highly sensitive to a 
variety of chemical substances (Solý’s et al., 1993). 
This method determines LC50 value of the active compounds and extract in saline 
medium in µg/mL (Massele and Nshimo, 1995). It has been used in research on 
medicinal plants carried out in different countries in order to evaluate toxicity, gastro-
protective action, and other biological actions. In some cases, it has been related to 
pharmacological studies carried out for different chemical compounds (Mathews, 1995; 
Fumaral and Garchitorena, 1996) where, it acts as a screening method mainly for 
products of plant origin (Parra et al., 2001).  
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2.5.2 Oral acute toxicity test 
Although acute toxicity test is considered simple, standard routine method, it has 
to be performed strictly in accordance with standard requirements, observing 
recommended conditions and using indicated organisms. Acute toxicity test is aimed to 
determine the concentration of plant extract that produces a harmful effect on a group of 
test organisms such as mice during a short-term exposure under controlled conditions. 
The most common acute toxicity test applied to animals is the acute lethality test 
(Sasidharan et al., 2008a). Lack of movement is normally recognized as a criterion of 
death (Rand and Petrocelli, 1985). Mortality is usually expressed as the median lethal 
concentration (LC50) whereby the estimated concentration of plant extract kills or 
immobilizes 50% of test organisms throughout the predetermined duration of time.  
2.6 Candida 
Candida species are ubiquitous fungi representing the most fungal pathogens that 
affect humans. The genus Candida includes around 200 species and the species are 
characterized primarily on morphology of the colony and carbon utilization. Candida is 
white asporogenous yeast capable of forming pseudohyphae. It is a yeast-like fungus 
which normally is present in bowel and feeds on sugars, simple carbohydrates and 
fermented products like alcohol and cheese. Some species are part of our microbiological 
flora and only 10% are known to be responsible for infections in people (Jarvis, 1995). 
There are seven Candida species of major medical importance; it most important and 
virulent which is frequently isolated is Candida albicans (McCullough et al., 1996). 
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2.6.1 Micromorphological characteristics of Candida spp.   
The colonies of Candida spp. microscopically are cream coloured to yellowish. 
The texture may be pasty, smooth, glistening or dry, wrinkled and dull depending on 
species. Microscopic features show important species related variations. All species 
produce blastoconidia, which may be rounded or elongated. Most produce pseudohyphae 
that are long, branched or curved. In addition, true hyphae and chlamydospores are 
produced by some Candida strains which observed in (Figure 2.2). Although members of 
the same genus, the various species present a degree of unique behavior with respect to 
their colony texture, microscopic morphology on cornmeal Tween 80 agar at 25
o
C 
(Dalmau method), and fermentation or assimilation profiles in biochemical tests that help 
to differentiate Candida from other yeasts (Freydiere et al., 2001).   
 
 
 
 
 
 
 
 
 
 
         Figure 2.2: Scanning electron microscopy image of a mature Candida spp.  
                            Biofilms are composed of yeast, hyphal and pseudohyphal elements. 
         (Source: Lopes-Ribot et al., 2004) 
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2.6.2 Mechanisms of resistance of Candida spp. 
There is several resistance mechanisms of Candida species been extensively 
documented by review journals (Sanglard and Odds, 2002).  In brief, resistance often 
arises from different synergetic combinations of a limited number of molecular 
mechanisms. These include the changes in cell wall or plasma membrane leading to an 
impaired uptake of antifungals, efflux pumps that take antifungals outside the cell, 
overexpression of the antifungal targets and mutations of the antifungal target that 
decrease its binding ability. Apart from that, the activation of alternate pathways that 
increase the metabolism of the antifungal and also the sequestration of the antifungal in 
Organelle-like vacuoles which change the structural content of cell wall are associated 
with the ability of some Candida strains to resist polyenes (Sanglard et al., 1997; Vanden 
Bossche et al., 1998; Marr et al., 2001).   
2.6.3 Pathophysiology and virulence factors of Candida spp. 
Candida spp. is part of the normal endogenous flora which is temporary or 
permanent carriage in the gastrointestinal tract. The mucocutaneous surface colonization 
is rare under normal condition (Jarvis, 1995) and it will be prerequisite for the 
development of candidiasis (Pittet et al., 1994; Wright and Wenzel, 1997). Secondary 
changes in the ecology of the endogenous flora will trigger the overgrowth of Candida 
spp. on mucosal and skin surfaces (Samonis et al., 1993). Furthermore, Candida spp. can 
also translocate across the gut barrier, while its integrity lost (Kennedy and Volz, 1985; 
Gianotti et al., 1993). The continuous exposure to risk factors is responsible for further 
invasion with possible secondary haematogenous dissemination (Figure 2.3) (Blumberg 
